Foreign vaccine curve into Chinese Switzerland novartis 1.25 billion purchase zhejiang tian yuan
|
Foreign vaccine curve into Chinese Switzerland novartis 1.25 billion purchase zhejiang tian yuan
Sources: xinhuanet 2011 08:27 on March 17, for two sentences I copy link (0) medium sized print medium once rumors "abortion" the world's fifth largest pharmaceutical enterprise Swiss novartis mergering Chinese vaccine company out again yesterday by case, the news of the approval from the ministry of commerce. It is reported, novartis will to the price of $125 million acquisition of equity. Zhejiang tian yuan 85%
Had been rumours m&a stalled
Novartis in early 2009, announced that it will with 1.25 billion takeover of tian yuan, when China is H1N1 influenza outbreak peak, approved by state food and drug administration, national including tian yuan a dozen vaccine enterprise can production sales armour flow vaccine, but foreign capital enterprise were excluded from the vaccine. Facing a huge amount of Chinese government purchase orders, a foreign-capital enterprise hard heart itch.
But the deal has been impending merger late last year, and rumors. Aground According to people familiar with the matter, the acquisition was introduced by the ministry of national work letter questioned. The get the approval from the ministry of commerce, said the takeover have finished almost. Yesterday, reporter from novartis (China) headquarters WangJianHui proofed this matter, media chief other gunshots: "we still not foreign released the news, particular case will be released at the end of this year."
Foreign vaccine curve into China
At present China has become the world's third-biggest vaccine market, and in the population, only to let any vaccine are coveted foreign capital enterprise.
"China has not enterprises with foreign capital in China, set up vaccine development is key obstacles of foreign enterprise in China see product demand, if only by the great demand for imports is not to choose. So many enterprises in China. Acquisition of domestic enterprises axed into one of the fastest means. The future is expected to similar mergers will more." A foreign vaccine enterprise market director told reporters.
(reporter HuangPei)
2009 November 3, Swiss novartis group announced that its will purchase one of China's largest private vaccine company of zhejiang tian yuan biological pharmaceutical 85% of equity, become the latter's stock shares. Novartis acquisition comes across a stream biological tian yuan, when, where the work already obtained letter of 20 million doses of influenza H1N1 influenza vaccine orders. With this acquisition, novartis is expected to become the first to enter the domestic armour flow vaccine supply sequence of foreign-invested enterprises. (sources: ZhongGuoWang)
|
|
Author Resource:-
I'm Xia zihui , it provides the high quality products, such as Child Tracking Device Manufacturer, GPS Car Tracking Device, Mini Pet Tracker, and many more.
|
By :
Jessie Stone
Submitted
2011-03-18 06:44:11 |
Article From Article Mayhem
 Ezine ready view |
|
|
|
Related Articles
|
|
|
![[Valid RSS feed]](http://www.articlemayhem.com/images/icon_Rss.png "XML Feed For RSS"){kind=icon}
Category Rss Feed![[Valid RSS feed]](http://www.articlemayhem.com/images/rss.jpg "XML Feed For RSS")